LB
LIfT BioSciences Ltd
LIfT BioSciences Ltd is a biotechnology company founded in 2016 by Alex Blyth. It develops an innovative allogeneic cell therapy called Neutrophil Only Leukocyte Infusion Therapy (N-LIfT) producing Immunomodulatory Alpha-Neutrophils (IMANs) designed to destroy cancer cells and replace pro-tumoral tumor-associated neutrophils, aiming to revolutionize the treatment of solid tumors.
Finanzierungsrunden
1
Gesamtvolumen
€12.0 Mio.
Letzte Runde
Seed
Investoren
7
Finanzierung nach Stage
Finanzierungsrunden
| Stage | Betrag | Investoren | Datum |
|---|---|---|---|
| Seed | €12.0 Mio. | 30. Juli 2025 |
